This 5-year grant will address the mechanisms of resistance to chemotherapy in highly aggressive breast cancers using cutting-edge methodologies, including testing our recently developed LOX inhibitors. NEW positions are available for highly motivated postdocs and graduate students.

Categories: Grant


Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *